Discover Our Latest News
Darolutamide Shows Promise in Phase III ARANOTE Trial for Treating Prostate Cancer
ONCOLife | 19 July 2024
ALTO-100 Trial: Next-Gen Depression Treatment Pioneering the Use of Cognitive Biomarkers
Psychiatry | 16 July 2024
Machine Learning Could Detect Disease from Protein Signatures 15 Years Before It Strikes
Digital Health | 15 July 2024
VISION Trial Employs AI and Digital Twins to Tailor Breast Cancer Treatment
ONCOLife | 10 July 2024
iOnctura and GSK Collaborate to Advance NSCLC Therapy with Roginolisib Trials
ONCOLife | 9 July 2024
Lung Cancer Research Foundation Names New Scientific Advisory Board Chair
FDA Approves Kisunla, a Novel Alzheimer's Therapy Targeting Amyloid Plaques
FDA & EMA | 3 July 2024
FDA Grants Fast-Track Designation to SYNC-T SV-102 for Hard-to-Treat Prostate Cancer
FDA & EMA | 2 July 2024
New Horizons in Schizophrenia Treatment: Trial of ALTO-101 Targets Cognitive Dysfunction
Psychiatry | 25 June 2024
FDA Approves Clinical Trials for ZW171: A Novel Bispecific Antibody for Hard-to-Treat Cancers
FDA & EMA | 21 June 2024
FDA Approves Grifols' Yimmugo® for Primary Immunodeficiency, Marking a Milestone
FDA & EMA | 18 June 2024
Unleashing the Potential of Neutrophil Cell Therapies in Oncology
ONCOLife | 10 June 2024
ASCO24: Opdivo Plus Yervoy Significantly Improves Overall Survival in Liver Cancer
ONCOLife | 7 June 2024
AbbVie Reveals Promising ADC Data for Advanced Cancer Treatments at ASCO 2024
ONCOLife | 3 June 2024
GenFleet's Fulzerasib Combo Achieves High Response Rate in Lung Cancer Treatment
ONCOLife | 2 June 2024
Tagrisso Extends Survival in Stage III EGFR-Mutated Lung Cancer Treatment
Scemblix® Outperforms Standard Treatments in Phase III Myeloid Leukemia Trial
ONCOLife | 31 May 2024
Spinogenix's Daily Pill SPG302 Receives FDA IND Nod for ALS Treatment
FDA & EMA | 29 May 2024
How Focused Ultrasound Could Change Treatment Options for Brain Cancers
ONCOLife | 28 May 2024
Genomic Testing Transforms Breast Cancer Care and Treatment Success
ONCOLife | 27 May 2024
Zai Lab Advances Psoriasis Treatment with ZL-1102 Topical Therapy in Phase 2 Trial
Clinical Trials | 25 May 2024
New Treatment for AA Hepatitis: Larsucosterol Earns FDA Breakthrough Designation
FDA & EMA | 24 May 2024
The Impact of CAR-T Cell Therapies on the Future of Pediatric Cancer Care
ONCOLife | 24 May 2024
Nimbus Reports Early Success in Treating Solid Tumors with NDI-101150, an HPK1 Inhibitor
Clinical Trials | 24 May 2024
Safer Non-Opioid Pain Relief on the Horizon: SRP-001 Shows Promise in Phase 1 Trials
Clinical Trials | 23 May 2024
Beyond Visualization: The Promise of VGT-309 in Minimally Invasive Lung Cancer Surgery
ONCOLife | 22 May 2024
FDA Approves IMDELLTRA for Lung Cancer After a 40% Response Rate
FDA & EMA | 17 May 2024
Pfizer Reports Promising Survival Benefits in Vepdegestrant Trial for Breast Cancer
Clinical Trials | 16 May 2024
Advancing Hepatitis B Cure: A Closer Look at Barinthus Bio's VTP-300 Project
Infections | 15 May 2024
A New Horizon in Oncology: FDA Approves the First-Ever mRNA Cancer Vaccine
FDA & EMA | 10 May 2024
Subscribe for the latest news and events
Most Popular
FDA Approves Wegovy to Reduce Risk of Heart Problems in Obese Adults
NETTER-2 Trial: Lutathera Cuts Risk of Death by 72% in Neuroendocrine Tumor Treatment
Transformative One-Time Gene Therapy: FDA Approves Pfizer's BEQVEZ, for Hemophilia B
New Horizon in Food Allergy Treatment: FDA Approves Xolair for All Ages
A New Era in Liver Disease: FDA Approves First Medication 'Rezdiffra' for NASH
FDA Approves Groundbreaking CAR T Cell Therapy, Abecma, for Multiple Myeloma
Novartis and Legend Biotech Strike $1 Billion Deal on CAR-T Therapy for Lung Cancer
A New Horizon in Rare Disease Treatment: FDA Approves Wainua for ATTR-PN
FDA Finds No Evidence Linking GLP-1 Weight-Loss Drugs to Suicidal Thoughts
FDA Approves Carvykti as Targeted CAR-T Cell Therapy for Multiple Myeloma
Revolutionary Molecular Jackhammers: A 99% Success Rate in Eradicating Cancer Cells
A New Phase in Bladder Cancer Treatment: Nivolumab Combination Wins FDA Approval
FDA Approves Keytruda in Combination with Chemo-radiotherapy for Cervical Cancer
ESMO 2023: BioNTech Unveils Groundbreaking Results for Solid Tumor Treatment